Avalo Therapeutics (AVTX) 10-Q2018 Q1 Quarterly report

Filed: 11 May 18, 12:11pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: absence, absorb, AcipHex, addendum, advantage, advertising, afforded, age, agreed, anniversary, approach, arbitration, Arbor, arose, assigned, assignment, assumption, attempted, attestation, authoritative, autonomic, Avadel, average, balloon, BB, behalf, beneficiary, billed, billing, break, Bulletin, called, capped, category, Cefaclor, centralization, CEO, channel, Chargeback, chewable, children, choosing, clearance, CMC, codification, comparison, competition, competitive, comply, composition, comprised, concentrated, consolidate, consolidated, consolidating, contemplated, CSF, customer, damaged, decline, declining, dedicated, Deerfield, deficiency, demand, description, detect, device, diet, dietary, differentiated, difficult, disaggregated, disbursement, disciplined, disease, dispensed, dispensing, dispute, dissolution, distributor, diversified, drinking, DSA, dysfunction, EBITDA, Eisai, electronic, elimination, emerging, emphasize, encourage, enhanced, entirety, ER, essential, exceed, expanded, exploit, facilitate, factor, faint, feel, field, fifteen, firm, Flamel, Flexichamber, Flor, fluoride, footprint, forthcoming, franchise, fraud, fraudulent, freight, Fremantle, frequently, FSC, fulfill, geographic, goal, goodwill, governmental, grow, Growing, growth, handling, healthcare, hypotension, identification, inability, incomplete, incremental, ind, indefinite, independent, indirectly, industry, input, insignificant, intangible, integrated, integration, intercompany, interpretation, introduction, inventory, invoice, invoiced, Ireland, Irish, issuable, joining, joint, Karbinal, Lachlan, larger, launch, led, leveraging, lice, lieu, line, LiquiTime, lived, lot, lowest, LRS, manner, marked, meaningful, meant, Medicaid, mentioned, Metafolin, Micropump, migration, Millipred, misstatement, mix, Motoric, move, multivitamin, negotiation, neurogenic, nOH, nominal, nonvested, obsolete, occupancy, older, open, opening, Operationally, orthostatic, oversight, owed, packaged, Parkinson, passed, past, pediatric, peer, people, perpetual, Pharm, Pharma, pharmaceutical, pharmacovigilance, pharmacy, pipeline, pivotal, PLC, poor, postural, preemptive, preliminary, prescription, President, prevent, primary, Princeton, promote, promoted, prompt, prospectively, protein, provisional, PSP, qualified, quality, quantitative, rare, reader, rebate, recipient, reconciliation, recoverable, redemption, regularly, reimburse, reimbursing, remediation, renew, representation, resolution, resolved, restructuring, retail, return, RSA, SAB, safeguard, safety, sector, seller, senior, shelf, shift, Shin, shipped, shipping, shorten, similarly, sinking, sit, skepticism, Sklice, solid, specialty, spending, Sprinkle, stability, stand, standing, step, stream, strongly, subordinated, subscription, subsidiary, substitute, supervision, supplement, supplemental, supply, support, suspension, synaptic, tablet, tangible, taxation, TCJA, team, territorial, territory, titled, top, transmission, Trump, TRx, type, typically, Ulesfia, unauthorized, uncertainty, underway, unrecognized, unrelated, USA, Veripred, VIE, vitamin, void, water, weighted, wholesale, wholesaler, wholly, winding, worth, written, yield, Yung, Zylera

Removed: acceptable, acceptance, adverse, altogether, anticipate, arise, ascending, audit, back, beneficial, cease, closed, commercialize, commercialized, communicated, conducted, continuing, contractually, default, Delaware, depending, depreciated, discontinue, dose, dosed, Eli, embedded, ensure, ensuring, excluding, exploration, facility, fail, FDA, file, foreseeable, furniture, gain, generalized, global, holder, Journal, leased, lien, Lilly, located, MDD, Merck, molecule, monitor, netted, nonfinancial, pending, portrayal, prime, profitability, pursue, receipt, reduced, relinquish, removed, retirement, Rule, scale, secondarily, secured, separately, simplify, small, software, Street, submit, successfully, suspend, sustain, sustainable, threatened, underwriting, upfront, valuable, Wall

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

AVTX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Cerecor Inc. (the “Registrant”) on Form 10-Q for the three months ended March 31, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Uli Hacksell, Chief Executive Officer of the Registrant, and I, Mariam E. Morris, Chief Financial Officer of the Registrant, each hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:


1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and


2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.



Date: May 11, 2018	By:	/s/ Peter Greenleaf
	Name:	Peter Greenleaf
	Title:	Chief Executive Officer (Registrant’s Principal Executive Officer)

Date: May 11, 2018	By:	/s/ Mariam E. Morris
	Name:	Mariam E. Morris
	Title:	Chief Financial Officer (Registrant’s Principal Financial and Accounting Officer)

The foregoing certifications are not deemed filed with the Securities and Exchange Commission for purposes of section 18 of the Securities Exchange Act of 1934, as amended (Exchange Act), and are not to be incorporated by reference into any filing of Cerecor Inc. under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.